Table 4.
Squamous cell carcinoma - Conjunctiva | DFS | OS | |
---|---|---|---|
No. | 1 year | 1 year | |
Gender | |||
Female | 15 | 60% | 80% |
Male | 20 | 83% | 89% |
Site | |||
Left | 13 | 92% | 92% |
Right | 22 | 61% | 82% |
Relapse preop. | |||
No | 25 | 74% | 84% |
Yes | 10 | 70% | 90% |
Vision loss | |||
No | 24 | 79% | 92% |
Yes | 11 | 73% | 73% |
Pain | |||
No | 26 | 71% | 88% |
Yes | 9 | 78% | 80% |
Type of exenteration | |||
Subtotal | 25 | 70% | 84% |
Total | 3 | ||
Extended | 7 | ||
ND | |||
No | 25 | 87% | 92% |
Yes | 10 | 32% | 69% |
Reconstruction | |||
None / Granulation | 1 | ||
Adaption | 1 | ||
Local flap | 32 | 74% | 87% |
Split skin | 1 | ||
Time of Reconstruction | |||
None | 1 | ||
Primary | 29 | 71% | 86% |
Secondary | 5 | ||
T | |||
1 | 2 | ||
2 | 3 | ||
3 | 13 | 82% | 92% |
4 | 17 | 63% | 81% |
N | |||
0 | 28 | 85% | 89% |
1–3 | 7 | 21% | 71% |
M | |||
0 | 34 | 75% | 88% |
1 | 1 | ||
G | |||
1 | 1 | ||
2 | 22 | 75% | 86% |
3 | 8 | 75% | 88% |
4 | 2 | ||
x | 2 | ||
L | |||
0 | 25 | 78% | 92% |
1 | 10 | 60% | 70% |
PNI | |||
0 | 32 | 81% | 90% |
1 | 3 | ||
R | |||
0 | 34 | 75% | 88% |
1+2 | 1 | ||
RTx pre | |||
No | 34 | 72% | 85% |
Yes | 1 | ||
Adj. RTx | |||
No | 34 | 72% | 85% |
Yes | 1 | ||
Adj. CTx | |||
No | 28 | 77% | 89% |
Yes | 7 | ||
Relapse | |||
No | 31 | 83% | |
Yes | 6 | 83% | |
-Local | 1 | - | |
-Lymph node | 5 | ||
-Distant met. | |||
Immunosuppression | |||
No | 27 | 78% | 93% |
Yes | 7 | 57% | 71% |
Second tumour | |||
No | 31 | 76% | 87% |
Yes | 4 |
(ND = neck dissection, T = extent of the primary tumour, N = spread to regional lymph nodes, M = presence of distant metastasis, G = grade of the tumour, L = invasion into lymphatic vessels, PNI = perineural invasion, R = resection-boundaries, RTx pre history of preoperative radiotherapy, Adj. RTx/CTx adjuvant radiotherapy/chemotherapy).